TD Cowen Maintains Outperform on Privia Health Gr, Lowers Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Gary Taylor has maintained an Outperform rating on Privia Health Group (NASDAQ:PRVA) but lowered the price target from $30 to $26.
March 01, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TD Cowen maintains an Outperform rating on Privia Health Group but lowers the price target from $30 to $26.
While the maintenance of an Outperform rating suggests continued confidence in the company's performance, the reduction in the price target could indicate a reassessment of the company's short-term growth prospects or market conditions. This mixed signal might lead to neutral short-term price movement as investors digest both the continued endorsement and the lowered expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100